Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

PURPOSE: The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data that test this paradigm are lacking. METHODS: We enrolled patients with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Palma, David A., Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V., Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B., Yaremko, Brian P., Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S., Laba, Joanna, Qu, X. Melody, Warner, Andrew, Senan, Suresh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2020
Konular:
RAPID COMMUNICATIONS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460150/
https://ncbi.nlm.nih.gov/pubmed/32484754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00818
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller